VolitionRx Limited (VNRX)
NYSEAMERICAN: VNRX · Real-Time Price · USD
0.4881
+0.0140 (2.95%)
At close: Aug 19, 2026, 4:00 PM EDT
0.4900
+0.0019 (0.39%)
Pre-market: Aug 20, 2026, 4:58 AM EDT

VolitionRx Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
2.461.731.230.780.310.09
Revenue Growth
86.32%40.04%59.10%153.04%240.30%570.25%
Gross Profit
2.461.731.230.780.310.09
Selling, General & Admin
12.513.3813.8517.2116.7515.4
Research & Development
9.4110.0814.4119.5515.3313.02
Operating Expenses
21.9123.4728.2636.7632.0928.42
Operating Income
-19.45-21.74-27.02-35.99-31.78-28.33
Interest Expense
-3.67-2.49-0.34-0.22-0.17-0.16
Interest & Investment Income
000.010.090.130
Other Non Operating Income (Expenses)
-1.040.720.130.451.231.52
EBT Excluding Unusual Items
-24.15-23.51-27.22-35.66-30.6-26.96
Gain (Loss) on Sale of Assets
00-0.03-0.02--0.03
Other Unusual Items
-1.58-----
Pretax Income
-25.73-23.5-27.26-35.68-30.6-26.99
Earnings From Continuing Operations
-25.73-23.5-27.26-35.68-30.6-26.99
Minority Interest in Earnings
0.090.150.290.360.330.18
Net Income
-25.64-23.36-26.97-35.32-30.27-26.81
Net Income to Common
-25.18-23.36-26.97-35.32-30.27-26.81
Net Income Growth
------
Shares Outstanding (Basic)
754433
Shares Outstanding (Diluted)
754433
Shares Change
44.16%23.46%21.47%28.70%5.12%16.29%
EPS (Basic)
-3.67-4.37-6.23-9.92-10.94-10.18
EPS (Diluted)
-3.80-4.37-6.23-9.92-10.94-10.18
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-19.58-19.77-26.17-19.15-16.85-21.83
Free Cash Flow Per Share
-2.85-3.70-6.05-5.38-6.09-8.29
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
-791.16%-1258.47%-2190.90%-4641.77%-10372.36%-31468.96%
Profit Margin
-1024.39%-1352.16%-2186.27%-4555.52%-9879.11%-29782.49%
Free Cash Flow Margin
-796.75%-1144.67%-2121.68%-2469.59%-5498.81%-24243.32%
EBITDA
-18.57-20.75-25.91-34.84-30.84-27.39
D&A For EBITDA
0.870.981.111.150.940.95
EBIT
-19.45-21.74-27.02-35.99-31.78-28.33
Revenue as Reported
2.461.731.230.780.310.09
SEC Filings: 10-K · 10-Q